世界の不妊治療サービスの2027年までの予測

Global Fertility Services Forecast to 2027

世界の不妊治療サービスの2027年までの予測市場概要市場拡大を加速させる主な市場ドライバーは、ストレスレベルの上昇、肥満、頻繁な喫煙、環境変数です。不安やうつ病などのライフスタイルの変化、過体重、... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Market Research Future マーケットリサーチフューチャー (MRFR)	2023年5月10日	US$7,250 ライセンス・価格情報注文方法はこちら	108	英語

目次
図表リスト

サマリー

世界の不妊治療サービスの2027年までの予測
市場概要
市場拡大を加速させる主な市場ドライバーは、ストレスレベルの上昇、肥満、頻繁な喫煙、環境変数です。不安やうつ病などのライフスタイルの変化、過体重、大量のアルコール摂取など、多くの社会的・環境的問題の結果として、受精サービスの必要性が大きくなっています。例えば、米国の半メディア機関であるNPRによると、2019年に比べて2020年に国内で生まれた子どもは4％減少しています。速報値では15歳から44歳の女性1000人あたりの出生数が55.8人で、合計特殊出生率はまたもや過去最低を更新しました。不妊率が上昇すると、不妊治療サービスのニーズが高まります。

セグメント別概要
基礎的な理由、治療法の種類、地域の洞察の3つが、世界の不妊治療サービスを構成する3種類のセグメント洞察である。

男性不妊症と女性不妊症は、根本的な原因に基づく不妊治療サービスの市場セグメンテーションに含まれます。

不妊治療サービスの市場データは、ARTに取り込まれる薬と不全の薬で区分されています。

高い比率は、不妊率の上昇、不妊治療サービスの認知度の向上、技術の進歩、政府の支援策によるものである。

地域別分析

本分析では、北米、欧州、アジア太平洋地域、その他の地域の地域別の市場洞察を提供しています。2021年に126億8700万ドルの売上を記録した欧州の不妊治療サービス市場は、調査期間を通じて大幅なCAGRで上昇すると予測されます。この高い割合は、失敗率の上昇、不妊治療サービスに対する認知度の向上、技術の進歩、政府の支援的な取り組みに起因しています。例えば、欧州生殖生物学会（European Society of Reproductive Biology and Embryology）によると、欧州連合（EU）は世界で最も不妊症の割合が高く、約2500万人が影響を受けています。北米は、予測期間中に大きく拡大すると予想されています。

主要プレイヤー

世界の不妊治療サービス分野には、Irvine Scientific Company Inc.、Cook Medical、Vitrolife、Monash IVF Group、Ferring B. V、Kitazato Cooperative、Care Fertilityなど、様々な事業者が存在します。

COVID-19の影響
COVID-19の流行は、当初不妊治療サービス市場にマイナスの影響を与えたが、多くの政府が不妊治療クリニックの復旧を奨励したため、急速に回復した（The Business Research Companyの世界不妊治療サービス産業の推定値）。不妊治療専門クリニックは、論理的に実現可能なルールを守り、病院の規定と一致させ、臨床指導者の意見と一致しているため、多くの人が不妊治療専門クリニックへの通院を希望していました。今後、COVID-19の接種率が向上することが予想され、不妊治療サービスの市場にとってプラスになると考えられます。また、同性婚の増加が市場の爆発的な拡大要因の一つであり、この傾向は予測期間中も続くと予想されます。同性カップルが体外受精に参加することで、体外受精サービスにも良い影響を与えることができます。この方法では、片方のパートナーが卵子を提供し、精子提供によって受精させ、もう片方のパートナーが妊娠することになります。したがって、同性カップルの増加により、不妊治療サービスの市場は拡大することになります。

ページTOPに戻る

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 13
1.1.1 MARKET SYNOPSIS 13
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 14
2.2 RESEARCH OBJECTIVE 14
2.3 LIST OF ASSUMPTIONS & LIMITATIONS 14
3 RESEARCH METHODOLOGY
3.1 OVERVIEW 16
3.2 DATA MINING 16
3.3 SECONDARY RESEARCH 17
3.4 PRIMARY RESEARCH 18
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 19
3.5 FORECASTING TECHNIQUES 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
3.6.1 BOTTOM-UP APPROACH 22
3.6.2 TOP-DOWN APPROACH 22
3.7 DATA TRIANGULATION 23
3.8 VALIDATION 23
4 MARKET DYNAMICS
4.1 OVERVIEW 24
4.2 DRIVERS 25
4.2.1 GROWTH IN THE MEDIAN AGE OF FIRST-TIME MOTHERHOOD AND DECLINING FERTILITY RATE 25
4.2.2 TECHNOLOGICAL ADVANCEMENTS IN FERTILITY TREATMENT 25
4.2.3 INCREASING PREVALENCE OF OBESITY AND CONSUMPTION OF ALCOHOL/CIGARETTES 25
4.2.4 DRIVERS IMPACT ANALYSIS 26
4.3 RESTRAINTS 26
4.3.1 HIGH PROCEDURAL COSTS OF ASSISTED REPRODUCTIVE TECHNIQUES IN DEVELOPED MARKETS 26
4.3.2 ETHICAL AND SOCIAL CONCERNS 27
4.3.3 RESTRAINTS IMPACT ANALYSIS 27
4.4 OPPORTUNITIES 28
4.4.1 REIMBURSEMENT FOR FERTILITY TREATMENTS 28
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 29
5.1.1 THREAT OF NEW ENTRANTS 29
5.1.2 BARGAINING POWER OF SUPPLIERS 30
5.1.3 THREAT OF SUBSTITUTES 30
5.1.4 BARGAINING POWER OF BUYERS 30
5.1.5 INTENSITY OF RIVALRY 30
5.2 VALUE CHAIN ANALYSIS 31
5.2.1 R&D AND DESIGNING 31
5.2.2 MANUFACTURING 32
5.2.3 DISTRIBUTION 32
5.2.4 MARKETING & SALES 32
5.2.5 POST-SALES MONITORING 32
5.3 COVID-19 IMPACT ANALYSIS 33
5.3.1 IMPACT ON GROWTH RATE 33
5.3.2 IMPACT ON MAJOR PLAYERS 33
5.3.3 IMPACT ON MAJOR REGIONS 33
6 GLOBAL FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE
6.1 OVERVIEW 34
6.2 FEMALE INFERTILITY 35
6.3 MALE INFERTILITY 36
7 GLOBAL FERTILITY SERVICES MARKET, BY TREATMENT TYPE
7.1 OVERVIEW 37
7.2 ASSISTED REPRODUCTIVE TECHNOLOGY (ART) 38
7.2.1 IN-VITRO FERTILIZATION (IVF) 39
7.2.2 FROZEN EMBRYO REPLACEMENT (FER) 39
7.2.3 ARTIFICIAL INSEMINATION 40
7.2.4 OTHERS 40
7.3 INFERTILITY DRUGS 41
8 GLOBAL FERTILITY SERVICES MARKET, BY REGION
8.1 OVERVIEW 42
8.2 EUROPE 43
8.2.1 WESTERN EUROPE 45
8.2.1.1 GERMANY 46
8.2.1.2 UK 47
8.2.1.3 FRANCE 48
8.2.1.4 ITALY 49
8.2.1.5 SPAIN 50
8.2.1.6 REST OF WESTERN EUROPE 51
8.2.2 EASTERN EUROPE 52
8.3 AMERICAS 54
8.3.1 NORTH AMERICA 56
8.3.1.1 US 57
8.3.1.2 CANADA 58
8.3.2 LATIN AMERICA 59
8.4 ASIA-PACIFIC 61
8.4.1 JAPAN 62
8.4.2 CHINA 63
8.4.3 INDIA 64
8.4.4 SOUTH KOREA 65
8.4.5 AUSTRALIA 66
8.4.6 REST OF ASIA PACIFIC 67
8.5 MIDDLE EAST & AFRICA 69
8.5.1 MIDDLE EAST 70
8.5.2 AFRICA 71
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW 73
9.2 MAJOR PLAYERS IN THE GLOBAL FERTILITY SERVICES MARKET 73
9.3 COMPETITIVE BENCHMARKING 74
9.4 COMPETITOR DASHBOARD 75
9.5 DEVELOPMENTS IN THE GLOBAL FERTILITY SERVICES MARKET 76
9.5.1 ACQUISITION 76
9.5.2 COLLABORATION 76
9.5.3 EXPANSION 76
9.5.4 DEVELOPMENT 77
9.5.5 JOINT VENTURE 77
9.5.6 PRODUCT LAUNCH/PRODUCT APPROVAL 77
10 COMPANY PROFILES
10.1 MERCK KGAA 78
10.1.1 COMPANY OVERVIEW 78
10.1.2 FINANCIAL OVERVIEW 79
10.1.3 PRODUCTS/SERVICES OFFERED 79
10.1.4 KEY DEVELOPMENTS 80
10.1.5 SWOT ANALYSIS 80
10.1.6 KEY STRATEGIES 81
10.2 COOPERSURGICAL, INC. 82
10.2.1 COMPANY OVERVIEW 82
10.2.2 FINANCIAL OVERVIEW 83
10.2.3 PRODUCTS/SERVICES OFFERED 83
10.2.4 KEY DEVELOPMENTS 84
10.2.5 SWOT ANALYSIS 85
10.2.6 KEY STRATEGIES 85
10.3 CARE FERTILITY 86
10.3.1 COMPANY OVERVIEW 86
10.3.2 FINANCIAL OVERVIEW 86
10.3.3 PRODUCTS/SERVICES OFFERED 86
10.3.4 KEY DEVELOPMENTS 87
10.3.5 SWOT ANALYSIS 87
10.3.6 KEY STRATEGIES 87
10.4 FERRING BV. 88
10.4.1 COMPANY OVERVIEW 88
10.4.2 FINANCIAL OVERVIEW 88
10.4.3 PRODUCTS/SERVICES OFFERED 88
10.4.4 KEY DEVELOPMENTS 89
10.4.5 SWOT ANALYSIS 89
10.4.6 KEY STRATEGIES 89
10.5 INVO BIOSCIENCE 90
10.5.1 COMPANY OVERVIEW 90
10.5.2 FINANCIAL OVERVIEW 90
10.5.3 PRODUCTS/SERVICES OFFERED 90
10.5.4 KEY DEVELOPMENTS 91
10.5.5 SWOT ANALYSIS 91
10.5.6 KEY STRATEGIES 91
10.6 VITROLIFE 92
10.6.1 COMPANY OVERVIEW 92
10.6.2 FINANCIAL OVERVIEW 92
10.6.3 PRODUCTS/SERVICES OFFERED 93
10.6.4 KEY DEVELOPMENTS 94
10.6.5 SWOT ANALYSIS 95
10.6.6 KEY STRATEGIES 95
10.7 MONASH IVF GROUP 96
10.7.1 COMPANY OVERVIEW 96
10.7.2 FINANCIAL OVERVIEW 96
10.7.3 PRODUCTS/SERVICES OFFERED 97
10.7.4 KEY DEVELOPMENTS 97
10.7.5 SWOT ANALYSIS 98
10.7.6 KEY STRATEGIES 98
10.8 COOK 99
10.8.1 COMPANY OVERVIEW 99
10.8.2 FINANCIAL OVERVIEW 99
10.8.3 PRODUCTS/SERVICES OFFERED 99
10.8.4 KEY DEVELOPMENTS 100
10.8.5 SWOT ANALYSIS 101
10.8.6 KEY STRATEGIES 101
10.9 FUJIFILM IRVINE SCIENTIFIC 102
10.9.1 COMPANY OVERVIEW 102
10.9.2 FINANCIAL OVERVIEW 102
10.9.3 PRODUCTS/SERVICES OFFERED 103
10.9.4 KEY DEVELOPMENTS 103
10.9.5 SWOT ANALYSIS 104
10.9.6 KEY STRATEGIES 104
10.10 KITAZATO CORPORATION 105
10.10.1 COMPANY OVERVIEW 105
10.10.2 FINANCIAL OVERVIEW 105
10.10.3 PRODUCTS/SERVICES OFFERED 105
10.10.4 KEY DEVELOPMENTS 106
10.10.5 SWOT ANALYSIS 106
10.10.6 KEY STRATEGIES 106
11 APPENDIX
11.1 REFERENCES 107
11.2 RELATED REPORTS 107

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 14
TABLE 2 GLOBAL FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 34
TABLE 3 GLOBAL FERTILITY SERVICES MARKET FOR FEMALE INFERTILITY, BY REGION, 2020-2027 (USD MILLION) 35
TABLE 4 GLOBAL FERTILITY SERVICES MARKET FOR MALE INFERTILITY, BY REGION, 2020-2027 (USD MILLION) 36
TABLE 5 GLOBAL FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 37
TABLE 6 GLOBAL FERTILITY SERVICES MARKET FOR ART, BY TYPE, 2020-2027 (USD MILLION) 38
TABLE 7 GLOBAL FERTILITY SERVICES MARKET FOR ART TREATMENT, BY REGION, 2020-2027 (USD MILLION) 39
TABLE 8 GLOBAL FERTILITY SERVICES MARKET FOR IN-VITRO FERTILIZATION (IVF), BY REGION, 2020-2027 (USD MILLION) 39
TABLE 9 GLOBAL FERTILITY SERVICES MARKET FOR FROZEN EMBRYO REPLACEMENT (FER), BY REGION, 2020-2027 (USD MILLION) 39
TABLE 10 GLOBAL FERTILITY SERVICES MARKET FOR ARTIFICIAL INSEMINATION, BY REGION, 2020-2027 (USD MILLION) 40
TABLE 11 GLOBAL FERTILITY SERVICES MARKET FOR OTHERS, BY REGION, 2020-2027 (USD MILLION) 40
TABLE 12 GLOBAL FERTILITY SERVICES MARKET FOR INFERTILITY DRUGS, BY REGION, 2020-2027 (USD MILLION) 41
TABLE 13 GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 42
TABLE 14 EUROPE: FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 43
TABLE 15 EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 44
TABLE 16 EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 44
TABLE 17 EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 44
TABLE 18 WESTERN EUROPE: FERTILITY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 45
TABLE 19 WESTERN EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 45
TABLE 20 WESTERN EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 46
TABLE 21 WESTERN EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 46
TABLE 22 GERMANY: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 46
TABLE 23 GERMANY: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 46
TABLE 24 GERMANY: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 47
TABLE 25 UK: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 47
TABLE 26 UK: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 47
TABLE 27 UK: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 48
TABLE 28 FRANCE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 48
TABLE 29 FRANCE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 48
TABLE 30 FRANCE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 49
TABLE 31 ITALY: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 49
TABLE 32 ITALY: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 49
TABLE 33 ITALY: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 50
TABLE 34 SPAIN: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 50
TABLE 35 SPAIN: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 50
TABLE 36 SPAIN: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 51
TABLE 37 REST OF WESTERN EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 51
TABLE 38 REST OF WESTERN EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 51
TABLE 39 REST OF WESTERN EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 52
TABLE 40 EASTERN EUROPE: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 52
TABLE 41 EASTERN EUROPE: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 52
TABLE 42 EASTERN EUROPE: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 53
TABLE 43 AMERICAS: FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 54
TABLE 44 AMERICAS: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 55
TABLE 45 AMERICAS: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 55
TABLE 46 AMERICAS: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 55
TABLE 47 NORTH AMERICA: FERTILITY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 56
TABLE 48 NORTH AMERICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 56
TABLE 49 NORTH AMERICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 56
TABLE 50 NORTH AMERICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 57
TABLE 51 US: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 57
TABLE 52 US: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 57
TABLE 53 US: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 58
TABLE 54 CANADA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 58
TABLE 55 CANADA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 58
TABLE 56 CANADA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 59
TABLE 57 LATIN AMERICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 59
TABLE 58 LATIN AMERICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 59
TABLE 59 LATIN AMERICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 60
TABLE 60 ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 61
TABLE 61 ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 62
TABLE 62 ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 62
TABLE 63 ASIA-PACIFIC: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 62
TABLE 64 JAPAN: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 62
TABLE 65 JAPAN: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 63
TABLE 66 JAPAN: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 63
TABLE 67 CHINA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 63
TABLE 68 CHINA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 63
TABLE 69 CHINA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 64
TABLE 70 INDIA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 64
TABLE 71 INDIA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 64
TABLE 72 INDIA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 65
TABLE 73 SOUTH KOREA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 65
TABLE 74 SOUTH KOREA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 65
TABLE 75 SOUTH KOREA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 66
TABLE 76 AUSTRALIA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 66
TABLE 77 AUSTRALIA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 66
TABLE 78 AUSTRALIA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 67
TABLE 79 REST OF ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 67
TABLE 80 REST OF ASIA-PACIFIC: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 67
TABLE 81 REST OF ASIA-PACIFIC: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 68
TABLE 82 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION) 69
TABLE 83 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 69
TABLE 84 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 70
TABLE 85 MIDDLE EAST & AFRICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 70
TABLE 86 MIDDLE EAST: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 70
TABLE 87 MIDDLE EAST: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 70
TABLE 88 MIDDLE EAST: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 71
TABLE 89 AFRICA: FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020-2027 (USD MILLION) 71
TABLE 90 AFRICA: FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 71
TABLE 91 AFRICA: FERTILITY SERVICES MARKET, FOR ART, BY TYPE, 2020-2027 (USD MILLION) 72
TABLE 92 MAJOR PLAYERS IN THE GLOBAL FERTILITY SERVICES MARKET 73
TABLE 93 COMPETITOR DASHBOARD: GLOBAL FERTILITY SERVICES MARKET 75
TABLE 94 ACQUISITION 76
TABLE 95 COLLABORATION 76
TABLE 96 EXPANSION 76
TABLE 97 DEVELOPMENT 77
TABLE 98 JOINT VENTURE 77
TABLE 99 PRODUCT LAUNCH/PRODUCT APPROVAL 77
TABLE 100 MERCK KGAA: PRODUCTS/SERVICES OFFERED 79
TABLE 101 MERCK KGAA: KEY DEVELOPMENTS 80
TABLE 102 COOPERSURGICAL, INC.: PRODUCTS/SERVICES OFFERED 83
TABLE 103 COOPERSURGICAL, INC.: KEY DEVELOPMENTS 84
TABLE 104 CARE FERTILITY: PRODUCTS/SERVICES OFFERED 86
TABLE 105 FERRING BV: PRODUCTS/SERVICES OFFERED 88
TABLE 106 FERRING BV: KEY DEVELOPMENTS 89
TABLE 107 INVO BIOSCIENCE: PRODUCTS/SERVICES OFFERED 90
TABLE 108 INVO BIOSCIENCE: KEY DEVELOPMENTS 91
TABLE 109 VITROLIFE: PRODUCTS/SERVICES OFFERED 93
TABLE 110 VITROLIFE: KEY DEVELOPMENTS 94
TABLE 111 MONASH IVF GROUP: PRODUCTS/SERVICES OFFERED 97
TABLE 112 MONASH IVF GROUP: KEY DEVELOPMENTS 97
TABLE 113 COOK: PRODUCTS/SERVICES OFFERED 99
TABLE 114 COOK: KEY DEVELOPMENTS 100
TABLE 115 FUJIFILM IRVINE SCIENTIFIC: PRODUCTS/SERVICES OFFERED 103
TABLE 116 FUJIFILM IRVINE SCIENTIFIC: KEY DEVELOPMENTS 103
TABLE 117 KITAZATO CORPORATION: PRODUCTS/SERVICES OFFERED 105
TABLE 118 KITAZATO CORPORATION: KEY DEVELOPMENTS 106

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Global Fertility Services Forecast to 2027
Market Overview
The primary market drivers accelerating market expansion are rising levels of stress, obesity, frequent smoking, and environmental variables. There is a significant need for fertilization services as a result of a number of social and environmental issues, including lifestyle modifications such as anxiety or depression, overweight, and heavy alcohol consumption. For instance, 4% fewer children were born in the nation in 2020 compared to 2019, as per NPR, a semi media institution in the US. At 55.8 births per 1,000 women aged between 15 to 44, according to preliminary data, the total fertility rate reached yet another record low. When infertility rates rise, there will be a greater need for fertility services.

Segment Overview
Underlying reason, Therapy type, and Regional Insights are the three types of segment insights that make up Global Fertility Services.

Male and female infertility are included in the market segmentation for fertility services based on the underlying cause.

The market data for fertility services has been divided by medication taken into ART and insufficiency medications.

The high percentage is attributed to a rise in the infertile rate, increased awareness of fertility services, technological advancements, and supportive government initiatives.

Regional Analysis

The analysis offers market insights for North America, Europe, Asia-Pacific, and the rest of the world, by region. The market for fertility services in Europe, which had sales of $ 12.6871 billion in 2021, is anticipated to rise at a substantial CAGR throughout the study period. The high percentage is attributed to a rise in the failure rate, increased awareness of fertility services, technological advancements, and supportive government initiatives. For instance, per the European Society of Reproductive Biology and Embryology, the European Union does have the highest proportion of infertile in the world, affecting almost 25 million people. North America is expected to expand significantly during the projection period.

Major Players

The Global Fertility Service Sector is home to a variety of businesses, including the Irvine Scientific Company Inc., Cook Medical, Vitrolife, Monash IVF Group, Ferring B. V, Kitazato Cooperative, and Care Fertility, among others.

COVID 19 Impacts
The COVID-19 pandemic initially had a negative impact on the market for fertility services, but it quickly rebounded with a boost as many governments encouraged the restoration of infertility clinics, according to The Business Research Company's estimate of the worldwide fertility services industry. Since they followed the rules that were logistically feasible in their clinical setup, aligned their protocols with their hospital regulations, and was in agreement with the views of their clinical leaders, many people were seeking intending to go to infertility centres. Future COVID-19 immunisation rates are predicted to improve, which will benefit the market for fertility services because many nations are already in the unlocking stage and couples seeking treatment won't need to put off their plans. The rise in same-sex marriages is one of the main factors contributing to the market's explosive expansion, and it is anticipated that this trend will continue during the projection period. By using Partnership IVF, a type of IVF for lesbian couples that allows both partners to become physically active in the creation of their kid, same-sex couples will have a good impact on the IVF services. In this procedure, one partner provides the eggs, which are fertilised by sperm donation, and the other partner becomes pregnant. The market for fertility services will therefore grow as a result of the rise in same-sex unions.

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Market Research Future社はどのような調査会社ですか?

マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。下記分野については、分野毎に専... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

世界の不妊治療サービスの2027年までの予測

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Market Research Future社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?